Clik here to view.
GN ReSound与Cochlear Limited成立智能听力联盟，共同开发双模式解决方案并使之商业化
丹麦哥本哈根和悉尼 (美国商业资讯)–智能助听器(Smart Hearing™)领域的领导者GN ReSound与植入式听力解决方案的全球领导者科利耳有限公司(Cochlear Limited) (ASX:COH)今天宣布缔结战略联盟，旨在开发全球最智能的双模式听力解决方案。这一创新合作将为更多患有轻度到重度听力损失的所有年龄层人群改善听力效果。它将助力听力健康专业人士简化听力解决方案的管理。...
View ArticleClik here to view.
Clik here to view.
Feld Entertainment 和 Primary Children’s Hospital宣布新的癌症研究筹款计划
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 佛罗里达州埃伦顿 (美国商业资讯)–Feld Entertainment, Inc.（ Ringling Bros. and Barnum & Bailey® 和Ringling Bros. Center for Elephant...
View ArticleClik here to view.
昆泰荣获2015 Frost & Sullivan亚太区年度CRO公司
新加坡 (美国商业资讯)–根据昆泰的创新、客户服务和增长，Frost & Sullivan将昆泰评选为Frost & Sullivan亚太区年度合同研究组织(CRO)。 Frost & Sullivan医疗保健合伙人Rhenu...
View ArticleClik here to view.
ジーエヌリサウンドとコクレアがスマート・ヒアリング・アライアンスを構築し、デュアルモード補聴ソリューションを開発・商業化へ
デンマーク・コペンハーゲン & シドニー （ビジネスワイヤ） — スマート・ヒアリング（Smart...
View ArticleClik here to view.
Vaxart to Present Key Data Related to Its Oral Norovirus and Seasonal...
SOUTH SAN FRANCISCO, Calif. Vaxart, Inc., a privately held, clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection,...
View ArticleClik here to view.
Cold Genesys Announces FDA Acceptance of a Phase I/II Clinical Trial Using...
SANTA ANA, Calif. Cold Genesys, Inc., a late-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration (FDA) accepted a Phase I/II Clinical Trial (NAOMI) using CG0070...
View ArticleClik here to view.
クインタイルズが3年連続で第I相サービスのリーダー企業として評価される
米ノースカロライナ州リサーチ・トライアングル・パーク （ビジネスワイヤ）– クインタイルズは、インダストリー・スタンダード・リサーチ（ISR）の2015年CROクオリティーベンチマーキング – 第I相サービスプロバイダー（2015 CRO Quality Benchmarking – Phase I Service...
View ArticleClik here to view.
Spectrum Pharmaceuticals Divests Rights to ZEVALIN® (ibritumomab tiuxetan) in...
HENDERSON, Nev. Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology,...
View ArticleClik here to view.
CSIRO Maintains Key Patent for shRNA Gene Silencing Technology After European...
CANBERRA, Australia Australia’s leading science agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), has successfully defended another key patent for RNA interference...
View ArticleClik here to view.
Cogstate iPad Cognitive Assessments Selected for Use in Phase IV...
NEW HAVEN, Conn. Cogstate Ltd (ASX:CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment technology has...
View ArticleClik here to view.
Dr. Reddy’s Issues a Clarification Note
HYDERABAD, India Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY): Reacting to certain statements that appeared in the media today relating to its corporate governance practices, Dr....
View ArticleClik here to view.
AmpliPhi Signs Clinical Trial Agreement with University of Adelaide to...
SAN DIEGO & RICHMOND, Va. & LJUBLJANA, Slovenia & SYDNEY AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in the development of bacteriophage-based antibacterial...
View ArticleClik here to view.
PD-1/PD-L1 Combinations Drive the Development of New Immunotherapies
BOSTON, LONDON & TOKYO The immuno-oncology agents Keytruda and Opdivo have already transformed the cancer care landscape. Now specialists are pairing them with approved or experimental agents to...
View ArticleClik here to view.
REMD Biotherapeutics Phase 2 Clinical Study of REMD-477 for Patients with...
CAMARILLO, Calif. REMD Biotherapeutics, Inc. (“REMD Bio”), together with its subsidiary, Beijing-based Cosci-REMD Biotherapeutics (“Cosci-REMD Bio”), today announced that its phase 2 clinical study...
View ArticleClik here to view.
New Survey Showed GI Health and Anti-Aging Benefits of Morinaga’s Probiotics...
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), Japanese leading dairy product company, today unveiled the results of a nationwide survey jointly conducted with Tokyo Healthcare University in...
View ArticleClik here to view.
Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Benepali®...
View ArticleClik here to view.
ノボキュア、初発膠芽腫のEF-14臨床試験データの新しい分析を含め、腫瘍治療電場に関するプレゼンテーション18件がSNO 2015で行われると発表
ジャージー島セントへリア （ビジネスワイヤ） — 商業段階のオンコロジー企業ノボキュア（NASDAQ: NVCR）は本日、腫瘍治療電場（Tumor Treating...
View ArticleClik here to view.
ゴアは性能に貢献して40周年を迎える中、世界でインプラントの販売数4000万個を達成
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、当社の40周年に合わせ、世界各国に4000万個以上のデバイスを販売したことを発表します。この大台となる成果は、当社がニューヨークの2015 VEITHsymposium®で血管科コミュニティー向けに最新の革新成果と業績を展示している中で達成されました。...
View ArticleClik here to view.
ZAI Lab and Hanmi Execute a License Agreement to Develop Novel EGFR Targeted...
SHANGHAI & SEOUL, South Korea ZAI Lab Limited and Hanmi Pharmaceutical Co., Ltd. (Hanmi)(KRX: 128940) announced today that they have executed a collaboration and license agreement under which...
View Article